- Previous Close
15.25 - Open
15.25 - Bid 11.27 x 29200
- Ask 12.04 x 29200
- Day's Range
15.25 - 15.25 - 52 Week Range
11.30 - 15.25 - Volume
200 - Avg. Volume
204 - Market Cap (intraday)
644.585M - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
48.23 - EPS (TTM)
0.26 - Earnings Date May 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.
www.surgicalscience.com274
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SUSRF
View MorePerformance Overview: SUSRF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SUSRF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SUSRF
View MoreValuation Measures
Market Cap
620.74M
Enterprise Value
546.46M
Trailing P/E
48.67
Forward P/E
26.32
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.25
Price/Book (mrq)
1.33
Enterprise Value/Revenue
6.10
Enterprise Value/EBITDA
37.35
Financial Highlights
Profitability and Income Statement
Profit Margin
14.89%
Return on Assets (ttm)
1.83%
Return on Equity (ttm)
2.87%
Revenue (ttm)
884.09M
Net Income Avi to Common (ttm)
131.65M
Diluted EPS (ttm)
0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
968.16M
Total Debt/Equity (mrq)
4.87%
Levered Free Cash Flow (ttm)
44.22M